Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesAnalysis of Subclassification by Size and Survival-associated Factors of StageI Non-small Cell Lung Cancer
Chinese Journal of Lung Cancer, 09/29/09
Ji H et al. – Histologic grade, preoperative anemia and tumor size are the independent prognostic factors in complete resection of stageI NSCLC. The patients with moderate–well differentiated histologic grade, non–preoperative anemia and smaller tumor size have longer survival time. Changes in tumor size classification are to subclassify into<=2 cm, 2.1 cm–3 cm, and 3.1 cm–5 cm, which is consistent with new T–staging system protocol of UICC.
Related Articles
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 68%
Comparative Proteomic Analysis of Human Lung Adenocarcinoma Cisplatin-resistant Cell Strain A549/CD
Chinese Journal of Lung Cancer, 11/24/09
Relevance Score: 67%
Image-Guided Radiofrequency Ablation of Lung Neoplasm in 100 Consecutive Patients by a Thoracic Surgical Service
Annals of Thoracic Surgery, 10/23/09
Relevance Score: 67%
The Association between Polymorphisms of XPD and Susceptibility of Lung Cancer: A meta Analysis
Chinese Journal of Lung Cancer, 10/21/09
Relevance Score: 67%
CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians
Lung Cancer, 10/06/09
Relevance Score: 67%
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy
Anti-Cancer Drugs, 12/09/09
Distinct Patterns of Cytokine and Angiogenic Factor Modulation and Markers of Benefit for Vandetanib and/or Chemotherapy in Patients With Non-Small-Cell Lung Cancer
Journal of Clinical Oncology, 12/09/09
Beta-Tubulin III mRNA expression and docetaxel sensitivity in non-small cell lung cancer
Clinical and Investigative Medicine, 12/09/09
Sponsor
Article Search
Sponsor